Form 4: ANI Pharmaceuticals Director Renee P. Tannenbaum Sells 2,000 Shares
SEC Form 4 Filing
Director Renee P. Tannenbaum sold 2,000 shares of ANI Pharmaceuticals Inc. on May 16, 2024, at a price of $63.87 per share.
Summary
- On May 16, 2024, Renee P. Tannenbaum, a director of ANI Pharmaceuticals Inc., sold 2,000 shares of the company's common stock.
- The sale price was $63.87 per share.
- Following the transaction, Tannenbaum directly owns 18,211 shares of ANI Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. The sale could be for personal financial management reasons and may not necessarily reflect a negative outlook on the company.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction relative to the director's total holdings.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of transaction: Renee P. Tannenbaum sold 2,000 shares of ANI Pharmaceuticals Inc. |
| 05/17/2024 | Date of signature: Form 4 signed by attorney-in-fact Meredith W. Cook. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.